Bugs Got Milk? Exploring the potential of lactose as a prebiotic ingredient for the human gut microbiota of lactose tolerant individuals

This was a result of a groundbreaking collaboration between Nintx and the Lactalis Group, the world's largest dairy company

Nintx leverages cutting-edge proprietary technologies like xGIbiomics® to develop multi-target therapies, which can modulate targets directly and indirectly via modulation of the gut microbiome. This innovative technology, mirroring the human gastrointestinal system, enables the development of our own R&D programs and fosters scientific collaborations to explore the impact of food, ingredients, and molecular entities on the human gut microbiota. Through Nintx’s advanced xGIbiomics® platforms (mini- and full-scale), the work developed by Nintx and Lactalis demonstrated that lactose promotes enhanced production of short-chain fatty acids and the growth of beneficial bacteria like Lactobacillus and Bifidobacterium. This research expands the nutritional value of dairy products. Beyond such important findings, our xGIbiomics® technology has proven to be a pivotal tool for the validation of scientific hypotheses, emphasizing its significance in gut microbiota research.

To have access to the full content, check us out on LinkedIn.

https://www.linkedin.com/posts/nintx_bugs-got-milk-exploring-the-potential-of-activity-7309929676783689731-I7Ug?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAAUL6oB6dOVqNQ7Ria1q2TMTlnb4Jf7Jwk